Introduction
============

Acute-onset postoperative endophthalmitis is characterized by marked inflammation of intraocular fluids and tissues. Gram-negative bacteria are less commonly isolated than Gram-positive bacteria in patients with acute-onset postoperative endophthalmitis. Gram-negative organisms have been isolated in 26%--42% of patients with cataract surgery related to endophthalmitis in developing countries,[@b1-opth-8-1783],[@b2-opth-8-1783] as compared with 5.9%--11.8% in developed countries.[@b3-opth-8-1783] The more common Gram-negative organisms causing endophthalmitis include species of *Pseudomonas*, *Haemophilus*, *Proteus*, and *Klebsiella*. There have been reports of multidrug-resistant strains of Gram-negative bacteria being isolated from patients with endophthalmitis.[@b4-opth-8-1783] Endophthalmitis caused by *Klebsiella pneumoniae* is associated with generally poor visual outcomes, despite treatment with appropriate antibiotics.[@b5-opth-8-1783] Three cases of acute postoperative endophthalmitis due to multidrug-resistant *K. pneumoniae* are reported.

Case reports
============

Three patients developed acute-onset endophthalmitis within 1--3 days following cataract surgery ([Table 1](#t1-opth-8-1783){ref-type="table"}). All the patients were in good general health and were not known to be suffering from any known systemic illness in the pre and postoperative periods. Presenting visual acuity ranged from 20/50 to light perception. Hypopyon was observed in all patients and corneal infiltrate was observed in two patients who presented with visual acuity of light perception.

One patient underwent vitreous tap with intraocular injection of vancomycin 1 mg/0.1 mL, amikacin 400 μg/0.1 mL, and dexamethasone 400 μg/0.1 mL. The other two patients underwent pars plana vitrectomy with intravitreal injection of the aforementioned antibiotics and dexamethasone. Gram-negative bacilli were isolated and confirmed to be *K. pneumoniae* by Vitek 2 compact (bioMérieux, France). Antibiotic susceptibility testing was determined by the Kirby--Bauer disk diffusion method ([Table 2](#t2-opth-8-1783){ref-type="table"}).

All isolates were multidrug resistant ([Table 2](#t2-opth-8-1783){ref-type="table"}) and were sensitive to imipenem. The organism that was isolated in case 3 was also found to be sensitive to ceftazidime and colistin.

Clinical deterioration was observed in all patients 2--3 days after initial intervention. Additional procedures in the form of pars plana vitrectomy with intravitreal injection of imipenem 50 μg/0.1 mL were carried out in all patients. Since there was no improvement 2 days after the second intervention, all patients were reinjected with intravitreal imipenem.

At last follow-up, visual acuity was poor in all the patients, there was light perception in two patients, and no light perception in the third patient. Phthisis bulbi occurred in two patients ([Table 1](#t1-opth-8-1783){ref-type="table"}).

Discussion
==========

Multidrug resistance is defined as acquired nonsusceptibility to at least one agent in three or more antimicrobial categories.[@b6-opth-8-1783] Incidences of multidrug-resistant Gram-negative bacilli have been increasing in tertiary care hospitals.[@b7-opth-8-1783] It was reported that 5.2% of microbiological isolates from endophthalmitis patients were multidrug resistant, and 78.6% of those isolates were Gram-negative bacteria.[@b4-opth-8-1783]

The various mechanisms contributing to virulence of *K. pneumoniae* are the presence of capsular K1/K2 serotypes, hypermucoviscosity, and the presence of the *magA* gene and the *bla~NDM-1~* gene, which is a carbapenemase β-lactamase.[@b7-opth-8-1783]--[@b9-opth-8-1783] These bacteria can be resistant to all currently available antimicrobial agents or remain susceptible only to older, potentially more toxic agents such as the polymyxins, leaving limited and suboptimal options for treatment.[@b6-opth-8-1783]

Intravitreal imipenem has been studied previously in rabbit eyes and has been reported to be nontoxic to retina.[@b10-opth-8-1783] It acts by inhibiting cell wall synthesis of various Gram-positive and Gram-negative bacteria. It is stable to hydrolysis by the common plasmid-mediated β-lactamases produced by various bacteria and lacks cross-resistance with penicillins and third-generation cephalosporins.[@b11-opth-8-1783] One case series reported use of intravitreal imipenem in the treatment of endophthalmitis caused by *Acinetobacter baumannii*. The authors reported that despite the use of multiple intravitreal injections of imipenem, the visual outcomes were poor.[@b12-opth-8-1783] Based on reported antimicrobial sensitivity, 50 μg/0.1 mL intravitreal imipenem was utilized in all patients in the current series.

*K. pneumoniae* has been commonly associated with endogenous endophthalmitis. In reported series, most patients have poor visual outcome despite appropriate antibiotic therapy, and the outcomes are usually phthisis and blindness.[@b5-opth-8-1783],[@b13-opth-8-1783] This may be attributed to the highly virulent organism as well as to delayed recognition of antibiotic resistance and susceptibility. The outcome of patients in the current case series was either phthisis or blindness, even after the best possible treatment.
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###### 

Intervention and visual outcome of multidrug-resistant *Klebsiella* endophthalmitis

  Case   Eye   Presenting visual acuity   Primary intervention             Number of intravitreal imipenem injections   Intraocular explantation   Final visual acuity   Outcome         Follow-up
  ------ ----- -------------------------- -------------------------------- -------------------------------------------- -------------------------- --------------------- --------------- -----------
  1      OS    20/50                      Vitreous biopsy + IOAB (V+A)     2                                            Yes                        LP, PR inaccurate     Phthisis        7 months
  2      OS    LP, PR accurate            PPV + IOAB (V+A)                 2                                            No                         LP, PR inaccurate     Optic atrophy   4 months
  3      OD    LP, PR inaccurate          PPV + IOL explant + IOAB (V+A)   2                                            Yes                        NLP                   Phthisis        1 month

**Abbreviations:** A, amikacin; IOAB, intraocular antibiotic; IOL, intraocular lens; LP, perception of light; NLP, no perception of light; OD, right eye; OS, left eye; PPV, pars plana vitrectomy; PR, projection of rays; V, vancomycin.

###### 

Antibiotic susceptibility patterns of *Klebsiella pneumoniae* isolates

  Antibiotic        Susceptibility result       
  ----------------- ----------------------- --- ---
  Amikacin          R                       R   R
  Chloramphenicol   R                       R   R
  Ciprofloxacin     R                       R   R
  Gatifloxacin      R                       R   R
  Moxifloxacin      R                       R   R
  Levofloxacin      R                       R   R
  Ceftazidime       R                       R   S
  Ceftriaxone       R                       R   R
  Ceftizoxime       I                       R   R
  Imipenem          S                       S   S
  Azithromycin      I                       I   R
  Co-trimoxazole    R                       R   R
  Colistin          R                       R   S
  Tetracycline      R                       R   R
  Erythromycin      R                       R   R
  Gentamicin        R                       R   R
  Neomycin          I                       I   I

**Abbreviations:** I, intermediate; R, resistant; S, sensitive.
